Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01133_DB01377_nanopub.RAtgfx1p462cIShPvMoeihbK4sw_JRpCILjveFpwvSXZM#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01133_DB01377 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01133_DB01377 label "DDI between Tiludronate and Magnesium oxide - The divalent cation of oral Magnesium oxide may significantly decrease the absorption of Tiludronate by forming a nonabsorbable chelate. Oral dosing should be separated by at least 2 hours. [drugbank_resource:DB01133_DB01377]" assertion.
- drugbank_resource:DB01133_DB01377 identifier "drugbank_resource:DB01133_DB01377" assertion.
- drugbank_resource:DB01133_DB01377 title "DDI between Tiludronate and Magnesium oxide - The divalent cation of oral Magnesium oxide may significantly decrease the absorption of Tiludronate by forming a nonabsorbable chelate. Oral dosing should be separated by at least 2 hours." assertion.
- drugbank:DB01377 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01133_DB01377 assertion.
- drugbank:DB01133 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01133_DB01377 assertion.